Thank you for subscribing to our blog.
We’ll hit your inbox next week with our latest post.

Latest Insights and Updates Delivered to your Inbox!

Subscribe now for exciting weekly industry news!

Steps to Developing Effective Patient Registries: Parkinson’s Foundation
Navitas Life Sciences will be at the Parkinson’s Foundation and Parkinson Study Group Annual Conference 2023 Patient registries are vital tools, orchestrating the collection of clinical data to advance the understanding and treatment of various conditions. We are delighted to be sponsoring the upcoming Future of Parkinson’s Disease: I...
Navitas Life Sciences’ Clinical Data Services: Showcasing at CPHI India 2023
Navitas Life Sciences boasts extensive experience in Clinical Data Services, covering a spectrum of crucial aspects including Data Management, Biostatistics & Programming, Data Standardization, Medical Writing, and Submissions. We are dedicated to delivering high-quality clinical trial data management while adhering to rigorous regulatory stand...
World Diabetes Day 2023: Supporting Diabetes Research through State-of-the-Art Euglycemic Clamp Studies
As we join the World Health Organization in observing the World Diabetes Day on November 14th, 2023, the global community faces an escalating diabetes crisis, demanding revolutionary advancements in therapeutic solutions. In this spirit, Navitas Life Sciences offers strategic partnerships to pharmaceutical companies, both large and small, in their ...
Leading Expert Insights on Drug Development and Immunology
Dr Narendra Chirmule Director of Biological Sciences at Symphony Technology In this exciting blog, we have the privilege of hearing from a seasoned expert, Dr Narendra Chirmule, PhD who has dedicated decades to advancing our understanding of immunology and pushing the boundaries of drug development. Dr Chirmule is a Director of Biological Sciences ...
Placing Patient Safety First: Preventing side effects and interactions with Medication Analysis
In our latest blog, Dr Philipp Hofmann, Director - Pharmacovigilance & QPPV, explores the significance of medication analysis, particularly for older patients in Germany. Offering a professional assessment, this analysis addresses crucial questions regarding potential adverse drug reactions and interactions. Dr Hofmann provides a comprehensive ...
pvindia Autumn forum success: Unlocking Pharmacovigilance Insights for a Safer World
In the ever-evolving landscape of Pharmacovigilance (PV), a parallel momentum is gaining traction — the imperative for transparency and heightened responsibility towards ensuring patient safety. Organizations operating in PV are now facing heightened pressure to demonstrate tangible progress. Transparency is the need of the hour. As we stand...
Our Experts Explore the Potential of Decentralized Clinical Trials and Our Unique Capabilities
In a rapidly evolving clinical research landscape, decentralized clinical trials (DCTs) have emerged as a transformative approach, providing an efficient way to conduct clinical trials. To explore the unique capabilities at Navitas Life Sciences, we interviewed Dr Atul Gupta, Vice President – Medical Services and Client Solutions and Dr Akas...
CPHI Barcelona 2023: Our Expert Leads the Way to the Future of Generics
Dr. Ayaaz Hussain Khan, Global Head of Generics at Navitas Life Sciences, will be a distinguished presence at CPHI 2023. With a wealth of experience and vast expertise, Dr. Khan will be present to find solutions for your unique needs and to provide a glimpse into the future of generics. In this blog, we spoke to Dr. Khan, to ask what CPHI North Bar...
Join Navitas Life Sciences at SCDM 2023
Navitas Life Sciences will showcase as a strategic partner at the upcoming SCDM Live Annual Conference – The Festival of Clinical Data Science, between 08 - 11 October 2023 in the Hilton San Diego Bayfront, San Diego, CA, USA. Our team of experts will be present to discuss insights that will transform your Clinical Data landscape. In this bl...
Meet Navitas Life Sciences at the World Drug Safety Congress for Future Ready Drug Safety Insights!
Navitas Life Sciences, a trusted global CRO, will be participating in the highly anticipated World Drug Safety Congress events in both America and Europe. With a legacy of excellence in pharmacovigilance, we will be present to discuss how we can support your PV needs with our expert insights and vast experience. Elevating Drug Safety Through Expert...

Solutions

Advisory Services

Clinical Development

Post Marketing

Therapeutics

Core Therapeutics

Interdisciplinary Therapeutics

Niche Therapeutics

Sectors

Governance

About Us